In a letter submitted to the House Energy and Commerce Subcommittee on Oversight and Investigations for a hearing on challenges implementing value-based and alternative payment models under the Medicare Access and CHIP Reauthorization Act of 2015, AHA encouraged certain statutory and regulatory policies to advance and flexibly implement these models. Recommendations include extending incentive payments; investing in resources and infrastructure to support rural hospitals’ transition to APMs; improving cost measures in the Merit-based Incentive Payment System; and supporting more gradual transitions to risk for certain Medicare Shared Savings Program accountable care organizations.  
 
“One additional factor that has impacted the transition to value-based care has been the longstanding challenges with insufficient reimbursement,” AHA said, including site-neutral payment cuts that have contributed to Medicare’s “chronic failure to cover the cost of caring for its beneficiaries.” The association said it “strongly opposes additional site-neutral payment cuts, which threaten access to care.”  

Headline
The AHA Aug. 5 provided comments to the Centers for Medicare & Medicaid Services on the distribution of funding for the Rural Health Transformation…
Headline
A bipartisan group of senators Aug. 5 introduced the Supporting Underserved and Strengthening Transparency, Accountability and Integrity Now and for the Future…
Headline
The U.S. District Court for the Eastern District of Pennsylvania Aug. 5 granted a motion for the AHA and the Hospital and Healthsystem Association of…
Headline
A blog by Shannon Wu, AHA director of payment policy, explains why having access to care close to home and the existence of rural hospitals are fundamental…
Blog
Public
Healthcare affordability discussions often focus on premiums, deductibles and drug prices. Those costs matter. But for the more than 46 million Americans who…
Headline
The Department of Health and Human Services today issued a notice announcing a revised 340B Rebate Model Pilot Program, allowing qualifying drug manufacturers…